Pharmacoinvasive Strategy in Acute STEMI

Recently, primary percutaneous coronary intervention (PCI) is the best option for reperfusion in STEMI patients, in clinical trials has lower rates of reinfarction, stroke and mortality than fibrinolytic therapy. Because of system delays in routine practice, prehospital administration of fibrinolyti...

Full description

Saved in:
Bibliographic Details
Published inMajalah kardiologi Indonesia Vol. 32; no. 4
Main Author Isman Firdaus
Format Journal Article
LanguageEnglish
Published Indonesian Heart Association 01.06.2013
Subjects
Acute Myocardial Infarction
Pharmacoinvasive
Online AccessGet full text

Cover

More Information
Summary:Recently, primary percutaneous coronary intervention (PCI) is the best option for reperfusion in STEMI patients, in clinical trials has lower rates of reinfarction, stroke and mortality than fibrinolytic therapy. Because of system delays in routine practice, prehospital administration of fibrinolytic therapy may lead to similar clinical outcomes, especially in those patients who present in early onset after symptom. Assessment of failed reperfu-sion for rescue PCI and invasive strategy after fibrinolitic therapy leading similar outcome with primary PCI. This review focuses on the timing of, and indications for, an invasive strategy after fibrinolytic therapy, including that for failed pharmacological reperfusion.
ISSN:0126-3773
2620-4762
DOI:10.30701/ijc.v32i4.88